Pneumocystis jiroveci pneumonia Information | Mount Sinai - New York
Pneumocystis Jirovecii (carinii) prophylaxis and pneumonia (PCP)
Table 2 from ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. | Semantic Scholar
Safety and efficacy of reduced-dose pentamidine as second-line treatment for HIV-related pneumocystis pneumonia - ScienceDirect
Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study | Annals of Intensive Care | Full Text
Therapy and prophylaxis of Pneumocystis jiroveci pneumonia a | Download Table
Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients | Respiratory Research | Full Text
Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study - ScienceDirect
Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation | European Respiratory Society
Characteristics of 15 HIV-Infected Patients Treated for Pneumocystis... | Download Table
Pathology of Pneumocystis Pneumonia - Dr Sampurna Roy MD
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text
Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients - ScienceDirect
Non‐HIV‐infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in‐hospital mortality - Wang - 2022 - The Clinical Respiratory Journal - Wiley
JoF | Free Full-Text | The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia